MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)
$31.54 1.53 (5.0983%)
Analysed MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) News Sources
Is Mineralys Therapeutics, Inc. (MLYS) A Good Stock To Buy Now?
03-05-2026
yahoo.com
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
05-05-2026
yahoo.com
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05-05-2026
yahoo.com
Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
06-05-2026
yahoo.com
Mineralys (MLYS) Q1 2026 Earnings Transcript
06-05-2026
fool.com
Mineralys Therapeutics, Inc. Q1 2026 Earnings Call Summary
07-05-2026
moby.co
Mineralys Therapeutics Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
How FDA NDA Acceptance for Lorundrostat At Mineralys Therapeutics (MLYS) Has Changed Its Investment Story
11-05-2026
yahoo.com
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
18-05-2026
yahoo.com
Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference
27-05-2026
yahoo.com
What is the current price of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The current price of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is $31.54.
MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) absolute price change since previous trading day?
The absolute price change of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) since the previous trading day is $1.53.
MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) percentage price change since previous trading day?
The percentage price change of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) since the previous trading day is 5.0983%.
What is the most recent average sentiment score for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The most recent average sentiment score for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The most recent sentiment for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is .
SEC-8K** Filing Available For MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.